MedCity News
MAY 7, 2023
Out of the $1 billion in Medicare payments to providers for psychotherapy services in the first year of Covid-19, $580 million were improper payments, an audit by the Office of Inspector General found. This includes $348 million for telehealth services.
PharmExec
MAY 7, 2023
This year marks my first involvement in Pharmaceutical Executive’s Emerging Pharma Leaders (EPL) Awards, and what a ride it has been. We received so many wonderful nominations, and it’s always humbling to learn about some of the intricacies of the research that’s being done as well as the accomplishments of both current leaders and up-and-coming leaders.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MedCity News
MAY 7, 2023
California lawmakers recently passed a bill that would provide interest-free cash loans to nonprofit and public hospitals undergoing significant financial distress. The loan program would provide up to $150 million in funds over the next couple years.
Pharmaceutical Technology
MAY 7, 2023
Formosa Pharmaceuticals along with AimMax Therapeutics has submitted a new drug application (NDA) to the US Food and Drug Administration (FDA) for APP13007, a new formulation to treat inflammation and pain after ocular surgery. APP13007 is an aqueous nanosuspension formulation of the potent corticosteroid, clobetasol propionate (0.05%). The homogeneous nanosuspension looks like a solution that provides improved comfort to the eyes and helps drug penetrate well into ocular tissues.
MedCity News
MAY 7, 2023
To positively impact the health of the most significant number of people, dentistry must be amplified by AI and truly become preventive care.
PharmExec
MAY 7, 2023
Click the title above for a link to open the Pharmaceutical Executive April 2023 issue in an interactive PDF format.
Expert insights. Personalized for you.
124 
Let's personalize your content